Mortality after nontraumatic intracerebral hemorrhage (ICH) remains poor with unchanged mortality 1 and Kaplan-Meier analyses showing 16 year cumulative survivals of 3.2% for men and 9.8% for women. 2 The multicenter, randomized controlled studies, INTERACT 2, and ATACH 2, evaluated the role of intensive blood pressure (BP) control in acute ICH, but failed to show statistically significant improvements in death or major disability. 3, 4 Post-hoc analysis of INTERACT 2 has suggested that other BP parameters, particularly systolic BP (SBP) variability, may play a role in clinical outcome. 5 Likewise, other literature has associated SBP variability with poor clinical outcome after ICH. [6] [7] [8] The role of other BP parameters, particularly diastolic BP (DBP), pulse pressure (PP), and mean arterial pressure (MAP) in clinical outcome after acute ICH remains largely unstudied. Clinically, widened PP has been associated with mortality in other pathologies, including sepsis, 9 cardiovascular disease, 10-12 hemodialysis, 13 and ischemic stroke, 14,15 as well as increasing stroke recurrence. 16, 17 However, the role of these BP parameters in acute ICH remains ambiguous. To date, no study has systematically evaluated the role of DBP, PP, and MAP with clinical outcome in acute ICH. We sought to evaluate the relationship of acute-onset SBP, DBP, PP, and MAP parameters with outcomes in patients with acute ICH. 
METHODS

Patient selection and study protocol
Institutional review board approval was obtained for the conduct of a prospective cohort study evaluating functional outcomes in adult nontraumatic ICH patients at a tertiarylevel mid-south university hospital. All data was prospectively collected as per hospital registry protocol for acute (<24 hours) ICH and retrospectively reviewed for accuracy by blinded neurologists (Y.K., K.D., A.K., and G.C.). Consecutive patients with ICH were initially identified by ICD code and spanned a 4-year period, January 2011 to December 2015. Inclusion criteria were as follows: spontaneous etiology for ICH and adult age (>18 years old). Exclusion criteria were as follows: nonspontaneous etiologies of ICH (including traumatic ICH, metastatic lesion with associated hemorrhage, ICH resulting from venous sinus thrombosis, and ICH resulting from underlying vascular lesions), ICH due to supratherapeutic international normalized ratio in the setting of prehospital anticoagulation or coagulopathy (threshold international normalized ratio ≥ 1.7), and thrombocytopenia (platelets < 50,000/mm 3 ).
All ICHs were initially admitted to the intensive care unit where BPs were monitored hourly via oscillometric cuff recordings. As per hospital protocol, patients were treated with continuous nicardipine infusion or intravenous pushes of enalapril, hydralazine, or labetalol to reach a goal SBP < 140 mm Hg during the first 24 hours after admission. If clinically stable, SBP parameters were relaxed to SBP goal <160 mm Hg after 24 hours of admission.
Non-BP related variables included demographic characteristics, past medical history, premorbid modified Rankin scores, and baseline radiological and clinical parameters. Baseline clinical severity was documented with National Institutes of Health Stroke Scale (NIHSS) scores. Clinical outcome endpoints included modified Rankin scores at discharge, hospital length of stay, and in-hospital mortality. In-hospital complications were also prospectively collected: decompressive hemicraniectomy, vasopressor use, respiratory failure (i.e., mechanical ventilation), and external ventricular drain placement.
BP variables
BP variability was evaluated by measuring the standard deviation of hourly recorded BPs over the first 12 hours after admission into the intensive care unit. Hourly PP was calculated using the relationship PP = SBP − DBP. Hourly MAP was calculated using the relationship MAP = (SBP − DBP)/3 + DBP. The following BP variables were evaluated: PP mean, PP variability, MAP mean, MAP variability, DBP mean, DBP variability, SBP mean, SBP variability, minimum SBP, maximum SBP, minimum DBP, and maximum DBP. Investigators documenting BP parameters (Y.K., K.D., A.K., G.C.) were blinded to patient outcomes.
Mortality analysis
Causes of mortality were delineated as follows. Cerebral herniation occurred when the patient reached a comatose state from herniation, was not formally declared brain dead, and passed away from cardiac death after palliative extubation. Brain death occurred when patients met clinical criteria which included loss of brainstem reflexes and apnea testing confirmation or ancillary testing for cerebral circulatory arrest. Spontaneous cardiac arrest occurred during an unanticipated cardiac arrest, unrelated to their primary ICH. Finally, palliative withdrawal occurred when the patient remained extubated for longer than 24 hours and was converted to comfort measures where the patient subsequently passed away.
Imaging characterization: ICH volume and hematoma expansion
Follow-up head computed tomography was acquired within 6-24 hours of initial computed tomography. ICH volume as noted in baseline computed tomography was measured as delineated by the ABC/2 score. 18 Hematoma expansion was defined as >33% expansion or >12.5 ml hematoma volume growth on serial computed tomographies taken within a 48 hour span. 8, 19, 20 All imaging was evaluated by a neuroradiologist blinded to clinical outcomes (J.B.).
Statistical analysis
Demographic characteristics and BP parameters between subgroups of patients (dichotomized into those who survived and died) were evaluated using χ 2 test, independent samples t-test, and Mann-Whitney U test as indicated. Cohen's d and odds ratios were reported as effect sizes. Normality of distribution for continuous variables was evaluated using the Kolmogorov-Smirnov goodness-of-fit test. Variables with a positive skew were normalized using the base 10 logarithm of the variable in order to fit the variables in multivariable logistic models.
ROC analyses were performed on SBP, DBP, and PP to determine threshold values associated with transitions from survival to in-hospital mortality. P-values associated with the null hypothesis that each ROC is significantly greater than an ROC of 0.50 are presented.
Initially, univariable analyses of potential predictors (demographic characteristics, vascular risk factors, NIHSS score, ICH score, BP parameters, location of ICH, intraventricular hemorrhage) were performed. Multivariable analyses were performed with logistic regression to identify predictors for in-hospital mortality. Covariates in our regression models included demographic variables that were significant at P < 0.001. ICH score was not included in multivariable analyses because of its high correlation with NIHSS score and intraventricular hemorrhage.
A series of 9 logistic regression analyses was performed using the covariates significant at P <0.001 (from Table 1 ) as the baseline covariate model. Subsequent models included covariates along with a combination of BP parameters. BP parameters for PP, DBP, and SBP were both included as continuous variables and dichotomized variables based off of the ROC curve. P-values from each covariate and BP-related predictor is presented along with odds ratios and 95% 
RESULTS
A total of 803 patients were initially identified by ICD code with 672 patients meeting inclusion criteria (mean age 61.6 ± 14.0 years, 56.4% men, median ICH score 1 (interquartile range: 0-2), and mean ICH hematoma volume 14.1 ± 18.1 cm 3 . Continuous cardene infusion was required in 60% of patients with the remainder receiving intravenous pushes of hydralazine, enalapril, or labetalol to reach targeted SBP goals. As hematoma volume was positively skewed, this variable was normalized using base 10 logarithm conversion, which resulted in a normalized distribution. The rate of in-hospital mortality was 24.1%.
Baseline characteristics for the in-hospital mortality and survival groups, including demographics, vascular risk factors, hospital course, in-hospital complications, and neuroimaging parameters are presented in Table 1 . Patients who died had larger hematoma volume (28.6 ± 25.0 vs. 9.4 ± 12.0, P < 0.001), higher mean admission NIHSS score (27.2 ± 11.4 vs. 7.4 ± 7.1, P < 0.001), higher median ICH score (3 [2] [3] [4] vs. 1 [0-2], P < 0.001), higher prevalence of intraventricular hemorrhage (76.4 vs. 35.1%, P < 0.001), higher admission creatinine (2.0 ± 2.3 vs. 1.4 ± 1.4, P = 0.001), and higher admission glucose (191.9 ± 100.0 vs. 142.4 ± 70.8, P < 0.001) than patients who survived. The mortality group also had significantly more complications (decompressive hemicraniectomy, respiratory failure, vasopressor use, and external ventricular device placement) (Table 1) .
When evaluating patients who died vs. survived during hospitalization, significant differences were noted for every BP parameter except for mean MAP and mean SBP ( Table 2) . Significantly higher variations (P < 0.001) for PP, MAP, SBP, and DBP were associated with mortality. Only PP and DBP showed significant differences between mortality and survival for both mean and variability values: the mortality group had a significantly higher PP mean (68.5 ± 16.4 mm Hg vs. 65.4 ± 12.4 mm Hg, P = 0.032). The mortality group also had a significantly higher PP variability (16.7 ± 8.5 mm Hg vs. 13.3 ± 5.2 mm Hg, P < 0.001). Conversely, mean DBP was significantly lower in the mortality group 76.5 ± 12.3 mm Hg when compared to the survival group 79.2 ± 11.2 mm Hg, P = 0.009. Figures 1-4 shows that when ROCs were plotted for mean and SDs of the BP parameters, AUC were consistently greater than 0.50 for the SD of PP, SBP, and DBP and for mean DBP. However, ROC curves for mean PP and mean SBP were shown to cross the reference line at certain threshold BP values (Figure 1 ), which provided a transition point delineating survival and in-hospital mortality. Using MedCalc, this transition point was used to evaluate an ROC threshold value where continuous BP parameters could be dichotomized. BP threshold values dichotomizing survival and mortality ( A series of models using multivariable logistic regression analysis with death as the dependent variable were evaluated using BP parameters (PP, DBP, and SBP) as both continuous and dichotomized predictors (Table 4) . Demographic characteristics from Table 1 with P < 0.001 were analyzed as covariates: log of admission hematoma volume, admission NIHSS, intraventricular hemorrhage, admission glucose, and admission creatinine. A baseline model without BP parameters (Table 4 , model 1) showed normalized hematoma volume, admission NIHSS, and creatinine to be independent predictors of death.
When adding BP parameters as continuous variables, no BP parameter emerged as an independent predictor (Table 4 , model 2). When using dichotomized BP parameters, only mean PP was a significant predictor of higher admission NIHSS scores, larger hematoma volume at presentation, and higher creatinine were independently associated with higher likelihood of in-hospital mortality (Table 4 , model 7). Higher dichotomized PP resulted in a 200% increased likelihood of in-hospital mortality (odds ratio, 3.0; 95% confidence interval, 1.7-5.3, P < 0.001).
DISCUSSION
Recent ICH treatment trials such as INTERACT 2 3 and ATACH 2 4 have targeted acute SBP reduction. Despite a lack of statistical significance, the trend toward improved 3-month outcomes noted in INTERACT 2 has led to an adoption of aggressive BP reduction as standard of care treatment. However, the failure of ATACH 2 to show improvement in clinical outcome, and an increased number of adverse events, 4 may prompt further debate regarding optimal BP management in acute ICH. We found a notable difference in that widened PP had the most significant effect on mortality with highest likelihood of mortality and remained an independent predictor (model 3) when all BP parameters were included in multivariable logistic regression analysis. This novel observation in acute ICH is consistent with previous literature focusing on chronic effects of widened PP on mortality in different pathologies, including cerebrovascular disease. [9] [10] [11] 16, 17 The relationship between widened PP and mortality in ICH remains unclear. Of particular uncertainty is whether this relationship represents a dynamic, potentially modifiable acute-phase process or a reflection of chronic underlying systemic atherosclerosis. 21 If we surmise on acute-phase mechanisms, one possibility is that decreased vascular compliance may require higher pulsatile pressure to support arterial blood flow. In such a process, higher PPs in hypertensive ICH may reflect a dynamic process where either stroke volume or systemic resistance augmentation predisposes patients to larger hematoma volume and worse functional outcome. In our study, this was not suggested. Hematoma volume on admission was found to be another independent predictor of mortality. However, no significant association was noted between hematoma expansion and mortality.
A second mechanism may lie with disruption of autoregulation and a resultant need to maintain adequate stroke volumes. The dysautoregulation associated with brain injuries such as ICH and resulting dependence on MAP for adequate cerebral perfusion pressure may necessitate a requirement for increasing stroke volume, which is reflected by widened PP due to an increased SBP component. Consequently, it may be hypothesized that intensive aggressive lowering of SBP, particularly in larger volume ICHs, creates an iatrogenic lowering of MAP and cerebral perfusion pressure in a dysautoregulated brain. However, an ischemic perihematomal penumbral area at risk for ischemia has never been documented by any neuroimaging modality including CT or magnetic resonance imaging perfusion studies. 22, 23 Furthermore, studies have shown that rapid SBP lowering in ICH is safe, 3, 24 while the adverse events associated with intensive SBP lowering in ATACH 2 only appeared to pertain to "renal adverse events". 4 A potential third mechanism may lie with higher PPs being associated with larger brain edema. SBP, DBP, and MAP were associated with brain edema in a cohort that included patients with ischemic stroke and ICH. 25 The potential mechanism linking BP parameters with vasogenic edema remains unclear although earlier papers have suggested blood-brain barrier disruption as the causative mechanism. 26 If DBP and PP is to be interpreted as an acutephase modifiable variable, future research must investigate the role of DBP, which reflects systemic vascular resistance and left ventricular afterload, with PP and ICH. 27 The findings of the present study support this hypothesis, since the driver behind the association between widened PP and increased in-hospital mortality was lower DBP.
Chronic hypertension may lead to a gradual decrease in arterial compliance, which is reflected in lower DBP and higher PP. 28, 29 If higher PP is merely a reflection of this chronic systemic vasculopathy, then our findings suggest a need to refocus ICH management on improved diagnostic and preventative therapies. This would include routine primary care or acute in-hospital work-ups that triage heart function with echocardiography and statin therapy 30, 31 that result in long-term strategies after hospital discharge designed to treat metabolic risk factors and chronic atherosclerosis (i.e., hyperlipidemia, diabetes, hypertension, smoking cessation, weight loss, and improved diet). With the majority of ICH caused by hypertensive crises, approaching the care of ICH patients with both intensive and chronic strategies to improve the health of systemic vasculature may produce the most substantial gains in long-term functional outcomes. Abbreviations: AUC, area under the curve; CI, confidence interval; DBP, diastolic blood pressure; PP, pulse pressure; ROC, receiver operating characteristics curve; SBP, systolic blood pressure.
a MedCalc used to identify cutoff values that maximized sensitivity and specificity.
Several limitations exist in the findings proposed in this paper. First, we used oscillometric noninvasive BP monitoring devices to obtain SBP and DBP. These devices inherently measure MAP, with algorithmic allocation of SBP and DBP variables, and the MAP reported by these devices is not mathematically similar to those that are calculated from derived SBP and DBP parameters. Ideally, arterial lines should be used to measure these pressures in a definitive study of arterial pressures in relation to ICH, but this may reduce feasibility. Second, intracranial pressures were not systematically recorded so any pathophysiologic relationship between decreased cerebral perfusion pressure, PP, and mortality could not be studied. Third is the retrospective nature of the data acquisition and single-center study, which may introduce bias. However, all variables were prospectively collected and collection of several variables, including hematoma volume, BP parameters, and mortality were collected by blinded personnel. Finally, this exploratory study failed to collect 3-month outcomes. Future work in this area should expand the timeline to include measurement of long-term outcomes to enable meaningful comparisons with other published work. In summary, the present study highlights widened acute PP levels as a novel independent predictor of in-hospital mortality in patients with spontaneous ICH. This observation underscores the importance of measuring PP in future trials that investigate the association between BP reduction and outcomes in ICH patients. Prospective studies incorporating larger numbers of patients with improved monitoring devices and longer monitoring durations are necessary to independently validate the present findings.
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